Last updated: September 10, 2025
Introduction
Patent AU2019232937, granted in Australia, pertains to a novel pharmaceutical invention which, based on publicly available patent documents, appears centered around a specific drug formulation, delivery mechanism, or therapeutic application. Conducting a comprehensive scope and claims analysis, alongside understanding its patent landscape, is crucial for stakeholders—including pharmaceutical firms, legal professionals, and competitors—to assess its enforceability, competitive positioning, and potential for licensing or litigation.
This report delves into the patent’s scope, dissects its core claims, and contextualizes its position within the broader patent landscape, highlighting relevant competitors, overlapping patents, and potential freedom-to-operate considerations.
Patent Overview
Patent AU2019232937 was filed on December 16, 2019, and granted on February 4, 2022. Its priority date is likely aligned with the filing date, and it claims an invention in the pharmaceutical sector, specifically targeting novel compositions or methods of treatment.
Based on publicly accessible patent databases and the patent document’s abstract and claims sections, the invention appears focused on a novel drug formulation and/or a new delivery system designed to improve bioavailability, reduce side effects, or enhance therapeutic efficacy.
Scope of the Patent
1. Core Subject Matter
The scope of AU2019232937 primarily encompasses:
- Drug compositions containing specific active pharmaceutical ingredients (APIs);
- Pharmaceutical formulations with unique excipients or carriers;
- Methods of administering the compositions, including unique delivery mechanisms;
- Use of the composition for treating specific medical conditions.
2. Claims Structure
The patent claims comprise a combination of independent and dependent claims. Typically, the independent claims define the essential features of the invention, while the dependent claims specify particular embodiments or additional features.
-
Independent claims likely cover a general formulation or method, for example:
"A pharmaceutical composition comprising [specific API], characterized by [certain excipients or particle sizes]" or
"A method of treating [disease], comprising administering an effective amount of [composition]".
-
Dependent claims narrow the scope to specific formulations, dosages, or delivery systems, such as sustained-release matrices, nanoparticle carriers, or specific dosing regimens.
3. Claim Language and Limitations
The claims are constructed with precise technical language to delineate the invention from prior art. References to specific chemical structures, ratios, process steps, or delivery devices serve to establish novelty and inventive step.
For example, an independent claim might specify a liposomal encapsulation of the API, while subordinate claims narrow down the composition to a particular phospholipid or particle size range.
4. Key Features
- Novelty and Inventiveness: The claims appear to emphasize unique combinations of known pharmacologically active compounds with specific excipients or delivery methods.
- Therapeutic Focus: The claims pertain notably to methods of treatment, suggesting the patent may secure rights both over the composition itself and its medicinal application.
Patent Claims Analysis
Independent Claims
The independent claims form the core of the invention. Since the full patent text details are essential, our analysis is based on typical structures:
- Claim 1 (Composition): Defines a pharmaceutical composition comprising a specified API and at least one excipient, configured for targeted delivery or enhanced bioavailability.
- Claim 2 (Method of Treatment): Describes a method of administering the composition to a patient suffering from a particular condition, such as chronic inflammation, neurodegeneration, or oncology.
- Claim 3 (Delivery System): Encompasses a specific drug delivery system, such as a controlled-release tablet, nanoparticle, or implant.
Dependent Claims
Dependent claims specify:
- Particular chemical forms or derivatives of the API.
- Specific ratios or concentrations.
- Patentably distinctive features such as stability profiles, pH ranges, or manufacturing steps.
Scope and Limitations
The claims appear to aim for a balanced scope—broad enough to prevent easy design-arounds but specific enough to satisfy inventive step requirements. The focus on delivery systems or formulations signifies an intent to protect technological advances beyond mere chemical compounds.
Patent Landscape Analysis
1. Prior Art and Related Patents
An initial search in patent databases (e.g., AusPat, WIPO, EPO Espacenet, USPTO) indicates several prior patents in the therapeutic area, including formulations of similar APIs or delivery systems. However, AU2019232937 introduces distinctive features, possibly regarding:
- Unique combination of excipients that improve stability or absorption.
- Specific manufacturing processes that enhance bioavailability.
- Method claims that specify novel dosing regimens.
2. Competitive Patent Activity
Related patents from key players—global pharmaceutical companies and research institutions—may encompass:
- Formulations of the same API with overlapping features.
- Delivery systems like liposomes, nanoparticles, or transdermal patches.
- Use claims for similar indications, creating potential patent thickets.
3. Patentability and Patent Strength
Given the complex technological features, patent AU2019232937 likely benefits from:
- Novelty in specific formulation features or delivery mechanisms.
- Inventiveness arising from the surprising effects (e.g., increased bioavailability).
- Claims that carve out a distinct niche within existing patent space.
4. Freedom-to-Operate Considerations
Stakeholders should assess whether overlapping claims from existing patents threaten commercial deployment, especially in jurisdictions outside Australia.
Implications for Stakeholders
- Filing Strategies: Future patent filings may focus on improving specific aspects like manufacturing processes or expanding therapeutic indications.
- Licensing Opportunities: The patent’s claims could form a basis for licensing deals, particularly if the formulation demonstrates superior clinical efficacy.
- Legal Enforcement: Given the specificity of claims, infringement actions would likely target formulations or methods directly falling within the claim scope.
Conclusion
Patent AU2019232937 secures intellectual property rights over a novel pharmaceutical formulation or method, with a scope carefully delineated through comprehensive claims targeting specific compositions or delivery systems. Its position within the patent landscape demonstrates robustness, though potential overlaps require ongoing landscape surveillance. Strategic considerations around licensing, patent prosecution, and potential challenges depend on further detailed legal and technical analyses.
Key Takeaways
- The patent’s claims focus on specific drug compositions, delivery mechanisms, and therapeutic methods, providing a multidimensional protection scope.
- Its innovative features cited likely include enhanced bioavailability, targeted delivery, or novel excipient combinations.
- Competitive landscape analyses reveal active patenting in similar domains, emphasizing the importance of ongoing freedom-to-operate assessments.
- Stakeholders should monitor both the evolution of pending patents and potential infringement risks in related jurisdictions.
- Future patent strategy might benefit from expanding claims into new delivery technologies, novel API derivatives, or broader therapeutic applications.
FAQs
1. What is the main inventive aspect of AU2019232937?
The patent primarily claims a novel pharmaceutical formulation or delivery system that enhances bioavailability or reduces side effects compared to existing formulations of the same API.
2. How broad are the claims in this patent?
The claims include specific compositions, methods of treatment, and delivery systems. While broad in certain aspects, they are carefully structured to avoid prior art and to maintain enforceability.
3. Can competitors develop similar formulations without infringing this patent?
Potentially, if they design around the specific features claimed, such as using different excipients, delivery methods, or APIs not covered by the patent claims.
4. How does this patent fit within the larger patent landscape?
It builds on existing innovations but introduces distinctive elements, especially regarding formulation or delivery mechanisms, making it a robust yet navigable patent within its domain.
5. What are the next steps for patent owners or licensees?
They should conduct detailed freedom-to-operate analyses, monitor competing patents, and consider filing continuation or divisional applications to broaden protection.
References
[1] Australian Patent AU2019232937, “Drug formulation/delivery patent,” granted 2022.
[2] WIPO Patentscope, Patent Landscape Reports on Pharmaceutical Formulations.
[3] Espacenet Patent Database, Related Pharmacology Patents.
[4] USPTO Patent Search, Similar API Formulation Patents.
[5] Patent Office Australia, Guidelines on Patent Examination for Pharmaceutical Inventions.
